Jefferies Group LLC Lumos Pharma, Inc. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
A detailed history of Jefferies Group LLC transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 120,651 shares of LUMO stock, worth $523,625. This represents 0.01% of its overall portfolio holdings.
Number of Shares
120,651
Previous 120,651
-0.0%
Holding current value
$523,625
Previous $929,000
16.79%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LUMO
# of Institutions
6Shares Held
168KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY41.1KShares$178,3910.0% of portfolio
-
Urban Wealth Management, LLC3.49KShares$15,1460.09% of portfolio
-
American Portfolios Advisors Holbrook, NY1.25KShares$5,4250.0% of portfolio
-
Wipfli Financial Advisors Llc,1.01KShares$4,3870.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ100Shares$4340.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $36.4M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...